Literature DB >> 21800041

EGFR expression in acquired middle ear cholesteatoma in children and adults.

Adriana Leal Alves1, Celina Siqueira Barbosa Pereira, Maria de Fatima Pereira Carvalho, Jose Humberto Tavares Guerreiro Fregnani, Fernando Quintanilha Ribeiro.   

Abstract

Middle ear cholesteatomas are characterized by the presence of keratinized stratified squamous epithelium inside this cavity. It is considered to be more aggressive in childhood. In normal skin, the epidermal growth factor receptor (EGFR) is expressed in the cytoplasmic membrane of epithelial cells of the basal layer. In contrast, its expression in middle ear cholesteatoma extends to suprabasal layers. The objective of this study is to detect the presence of EGFR in cases of acquired cholesteatoma of the middle ear and correlate the expression of this receptor with patients' ages. In this cross-sectional study, cholesteatoma samples were collected from 50 patients (35 adults and 15 children) who underwent otological surgery, throughout 1 year of study. These samples were subjected to histological and immunohistochemical assays. Results were submitted to statistical analyses and main findings were: EGFR was present in the parabasal layers in 27 cases and EGFR expression was extended to all layers of the matrix in 17 cases. There were no statistically significant differences in what concerns age-related variances in EGFR expression. The intensity and location of EGFR expression in acquired cholesteatoma of the middle ear confirm the hyperproliferative capacity of keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21800041     DOI: 10.1007/s00431-011-1526-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

1.  Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression.

Authors:  J Bujía; C Kim; A Holly; H Sudhoff; P Ostos; E Kastenbauer
Journal:  Am J Otol       Date:  1996-03

2.  Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth?

Authors:  F Ottaviani; C B Neglia; E Berti
Journal:  Acta Otolaryngol       Date:  1999       Impact factor: 1.494

3.  Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1.

Authors:  J Bujía; A Holly; F Antolí-Candela; M G Tapia; E Kastenbauer
Journal:  Laryngoscope       Date:  1996-07       Impact factor: 3.325

Review 4.  Epidermal growth factor receptor: mechanisms of activation and signalling.

Authors:  Robert N Jorissen; Francesca Walker; Normand Pouliot; Thomas P J Garrett; Colin W Ward; Antony W Burgess
Journal:  Exp Cell Res       Date:  2003-03-10       Impact factor: 3.905

5.  Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha.

Authors:  P Schulz; J Bujía; A Holly; V Shilling; E Kastenbauer
Journal:  Am J Otolaryngol       Date:  1993 Mar-Apr       Impact factor: 1.808

6.  Functional characterization of middle ear mucosa residues in cholesteatoma samples.

Authors:  H Sudhoff; J Bujía; A Holly; C Kim; A Fisseler-Eckhoff
Journal:  Am J Otol       Date:  1994-03

7.  Cholesteatoma in children.

Authors:  A Palva; P Karma; J Kärjä
Journal:  Arch Otolaryngol       Date:  1977-02

8.  Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium.

Authors:  J W Chung; T H Yoon
Journal:  Acta Otolaryngol       Date:  1998-06       Impact factor: 1.494

9.  Expression of epidermal growth factor receptor in human middle ear cholesteatoma.

Authors:  Ying-Che Hsu; Kuen-Yao Ho; Chee-Yin Chai; Ka-Wo Lee; Ling-Feng Wang; Shu-Chuan Wu; Wen-Rei Kuo; Shin-Meng Tsai
Journal:  Kaohsiung J Med Sci       Date:  2003-10       Impact factor: 2.744

10.  Correlation of cholesteatomas perimatrix thickness with patient's age.

Authors:  Cristina Dornelles; Sady Selaimen da Costa; Luíse Meurer; Cláudia Schweiger
Journal:  Braz J Otorhinolaryngol       Date:  2005 Nov-Dec
View more
  2 in total

1.  Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium.

Authors:  Wei Liu; Tuanfang Yin; Jihao Ren; Lihua Li; Zian Xiao; Xing Chen; Dinghua Xie
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-05       Impact factor: 2.503

2.  The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma.

Authors:  Wei Liu; Hongmiao Ren; Jihao Ren; Tuanfang Yin; Bing Hu; Shumin Xie; Yinghuan Dai; Weijing Wu; Zian Xiao; Xinming Yang; Dinghua Xie
Journal:  Mediators Inflamm       Date:  2013-11-07       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.